Skip to main content
NVO
NYSE Life Sciences

Novo Lifts Full-Year Outlook as Wegovy Pill Demand Beats Expectations

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$41.96
Mkt Cap
$178.825B
52W Low
$35.12
52W High
$64.16
52W Position info
19% above low
Off High info
35% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

NVO sits 19% above its 52-week low of $35.12.

Summary

Novo raised its full-year outlook to a range of -2% to +2% at constant exchange rates, a big step up from the prior guidance of declines of up to 6%. Q3 net sales came in at DKK 79.19B, up 6% year over year, while reported operating profit fell 3% to DKK 23B; adjusted operating profit rose 34% to DKK 31.7B and beat estimates. The Wegovy pill did the heavy lifting at DKK 5.39B in sales, above expectations, and management said it should reach more than 20 markets next year. Ozempic held up better than feared, which matters because this is the same GLP-1 franchise that has been under pressure from Eli Lilly's oral push. Separately, Novo named Luigi La Corte of Galderma to succeed CFO Karsten Munk Knudsen, who stays through the end of December. The guidance raise is the headline for traders: it resets the earnings floor after a year of cuts and puts the oral obesity race with Lilly back in focus.

At the time of this announcement, NVO was trading at $41.96 on NYSE in the Life Sciences sector, with a market capitalization of approximately $178.8B. The 52-week trading range was $35.12 to $64.16. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

NVO - Latest Insights

NVO
Nov 04, 2026, 8:35 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $42.91
Real-time Price: $38.01 info
Change: -$4.89 (-11%) info
Market Cap: $171.957B info
NVO
Nov 04, 2026, 7:47 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $42.90
Real-time Price: $38.01 info
Change: -$4.89 (-11%) info
Market Cap: $171.957B info
NVO
Oct 27, 2026, 3:10 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.16
Real-time Price: $38.01 info
Change: -$1.15 (-3%) info
Market Cap: $171.957B info
NVO
Oct 02, 2026, 5:53 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.88
Real-time Price: $38.01 info
Change: +$1.13 (+3%) info
Market Cap: $171.957B info
NVO
Sep 29, 2026, 7:08 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $38.43
Real-time Price: $38.01 info
Change: -$0.4175 (-1%) info
Market Cap: $171.957B info